ask="N/A"
ask_size="N/A"
average_daily_volume="188323"
bid="17.65"
bid_size="2100"
book_value="7.04"
change="+0.73"
change_from_200_day_moving_average="5.12"
change_from_50_day_moving_average="0.93"
change_from_52_week_high="-2.45"
change_From_52_week_low="9.50"
change_in_percent="+3.43%"
close="21.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18634000"
high="22.15"
high_52_weeks="24.30"
last_trade_date="2/3/2017"
last_trade_price="21.85"
last_trade_size="10092"
last_trade_time="4:00pm"
low="21.05"
low_52_weeks="12.35"
market_capitalization="623.05M"
moving_average_200_day="16.73"
moving_average_50_day="20.92"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="21.40"
pe_ratio="N/A"
peg_ratio="-0.57"
percent_change_from_200_day_moving_average="+30.59%"
percent_change_from_50_day_moving_average="+4.44%"
percent_change_from_52_week_high="-10.08%"
percent_change_from_52_week_low="+76.92%"
previous_close="21.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.00"
price_per_sales="2007.93"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="22.14"
stock_exchange="NGM"
symbol="RVNC"
volume="188919"
weeks_range_52="12.35 - 24.30"
